ELISA was employed to measure the levels of IL-6, p53, and cytochrome C. The combination of LES-6400 (1 μM) and trastuzumab (10 μg/mL) demonstrated superior antitumor activity compared to monotherapy with either agent in AGS gastric cancer cells. This evidence concerns the gene IL6 and gastric cancer.